Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents

Abstract Objective: This study aimed to compare two self-expanding stents, a nitinol stent and an elgiloy stent, both placed percutaneously, in terms of their efficacy in palliating inoperable malignant biliary obstruction. Materials and Methods: We retrospectively investigated 99 patients with unresectable malignant biliary obstruction treated with percutaneous placement of a self-expanding metallic stent at our institution between May 2007 and January 2010. Serum bilirubin and liver enzyme levels were measured before and 30 days after stenting. For all procedures using elgiloy or nitinol stents, stent occlusion and patient survival rates were calculated using Kaplan-Meyer analysis. Results: All of the patients showed clinical improvement after stent placement, with no difference between the two groups. In both groups, the occlusion-free survival rate was 67% at 30 days, 37% at 90 days, 25% at 180 days, and 10% at 360 days, with no significant difference in relation to the type of stent. Conclusion: The two stents evaluated showed comparable efficacy for the percutaneous treatment of unresectable biliary malignancy, with good clinical results.

Saved in:
Bibliographic Details
Main Authors: Zurstrassen,Charles Edouard, Bitencourt,Almir Galvão Vieira, Guimaraes,Marcos Duarte, Cavalcante,Aline Cristine Barbosa Santos, Tyng,Chiang Jeng, Amoedo,Mauricio Kauark, Matsushita Junior,João Paulo Kawaoka, Szklaruk,Janio, Marchiori,Edson, Chojniak,Rubens
Format: Digital revista
Language:English
Published: Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem 2017
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842017000200097
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-39842017000200097
record_format ojs
spelling oai:scielo:S0100-398420170002000972017-04-24Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stentsZurstrassen,Charles EdouardBitencourt,Almir Galvão VieiraGuimaraes,Marcos DuarteCavalcante,Aline Cristine Barbosa SantosTyng,Chiang JengAmoedo,Mauricio KauarkMatsushita Junior,João Paulo KawaokaSzklaruk,JanioMarchiori,EdsonChojniak,Rubens Radiology, interventional Drainage Stents Biliary tract/pathology Oncology Abstract Objective: This study aimed to compare two self-expanding stents, a nitinol stent and an elgiloy stent, both placed percutaneously, in terms of their efficacy in palliating inoperable malignant biliary obstruction. Materials and Methods: We retrospectively investigated 99 patients with unresectable malignant biliary obstruction treated with percutaneous placement of a self-expanding metallic stent at our institution between May 2007 and January 2010. Serum bilirubin and liver enzyme levels were measured before and 30 days after stenting. For all procedures using elgiloy or nitinol stents, stent occlusion and patient survival rates were calculated using Kaplan-Meyer analysis. Results: All of the patients showed clinical improvement after stent placement, with no difference between the two groups. In both groups, the occlusion-free survival rate was 67% at 30 days, 37% at 90 days, 25% at 180 days, and 10% at 360 days, with no significant difference in relation to the type of stent. Conclusion: The two stents evaluated showed comparable efficacy for the percutaneous treatment of unresectable biliary malignancy, with good clinical results.info:eu-repo/semantics/openAccessPublicação do Colégio Brasileiro de Radiologia e Diagnóstico por ImagemRadiologia Brasileira v.50 n.2 20172017-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842017000200097en10.1590/0100-3984.2015.0183
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Zurstrassen,Charles Edouard
Bitencourt,Almir Galvão Vieira
Guimaraes,Marcos Duarte
Cavalcante,Aline Cristine Barbosa Santos
Tyng,Chiang Jeng
Amoedo,Mauricio Kauark
Matsushita Junior,João Paulo Kawaoka
Szklaruk,Janio
Marchiori,Edson
Chojniak,Rubens
spellingShingle Zurstrassen,Charles Edouard
Bitencourt,Almir Galvão Vieira
Guimaraes,Marcos Duarte
Cavalcante,Aline Cristine Barbosa Santos
Tyng,Chiang Jeng
Amoedo,Mauricio Kauark
Matsushita Junior,João Paulo Kawaoka
Szklaruk,Janio
Marchiori,Edson
Chojniak,Rubens
Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
author_facet Zurstrassen,Charles Edouard
Bitencourt,Almir Galvão Vieira
Guimaraes,Marcos Duarte
Cavalcante,Aline Cristine Barbosa Santos
Tyng,Chiang Jeng
Amoedo,Mauricio Kauark
Matsushita Junior,João Paulo Kawaoka
Szklaruk,Janio
Marchiori,Edson
Chojniak,Rubens
author_sort Zurstrassen,Charles Edouard
title Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
title_short Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
title_full Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
title_fullStr Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
title_full_unstemmed Percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
title_sort percutaneous stent placement for the treatment of malignant biliary obstruction: nitinol versus elgiloy stents
description Abstract Objective: This study aimed to compare two self-expanding stents, a nitinol stent and an elgiloy stent, both placed percutaneously, in terms of their efficacy in palliating inoperable malignant biliary obstruction. Materials and Methods: We retrospectively investigated 99 patients with unresectable malignant biliary obstruction treated with percutaneous placement of a self-expanding metallic stent at our institution between May 2007 and January 2010. Serum bilirubin and liver enzyme levels were measured before and 30 days after stenting. For all procedures using elgiloy or nitinol stents, stent occlusion and patient survival rates were calculated using Kaplan-Meyer analysis. Results: All of the patients showed clinical improvement after stent placement, with no difference between the two groups. In both groups, the occlusion-free survival rate was 67% at 30 days, 37% at 90 days, 25% at 180 days, and 10% at 360 days, with no significant difference in relation to the type of stent. Conclusion: The two stents evaluated showed comparable efficacy for the percutaneous treatment of unresectable biliary malignancy, with good clinical results.
publisher Publicação do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem
publishDate 2017
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-39842017000200097
work_keys_str_mv AT zurstrassencharlesedouard percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT bitencourtalmirgalvaovieira percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT guimaraesmarcosduarte percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT cavalcantealinecristinebarbosasantos percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT tyngchiangjeng percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT amoedomauriciokauark percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT matsushitajuniorjoaopaulokawaoka percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT szklarukjanio percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT marchioriedson percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
AT chojniakrubens percutaneousstentplacementforthetreatmentofmalignantbiliaryobstructionnitinolversuselgiloystents
_version_ 1756386869695741953